<SEC-DOCUMENT>0001213900-17-002473-index.html : 20170316
<SEC-HEADER>0001213900-17-002473.hdr.sgml : 20170316
<ACCEPTANCE-DATETIME>20170316164557
ACCESSION NUMBER:		0001213900-17-002473
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20170316
DATE AS OF CHANGE:		20170316
EFFECTIVENESS DATE:		20170316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Actinium Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001388320
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880378336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-216746
		FILM NUMBER:		17695143

	BUSINESS ADDRESS:	
		STREET 1:		275 MADISON AVENUE, 7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		646-677-3875

	MAIL ADDRESS:	
		STREET 1:		275 MADISON AVENUE, 7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cactus Ventures, Inc.
		DATE OF NAME CHANGE:	20070130
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>fs82017_actiniumpharmaceutic.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
Document 1 - file: fs82017_actiniumpharmaceutic.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>fs82017ex5i_actiniumpharma.htm
<DESCRIPTION>OPINION OF THE MATT LAW FIRM, PLLC
<TEXT>
Document 2 - file: fs82017ex5i_actiniumpharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>fs82017ex23i_actiniumpharma.htm
<DESCRIPTION>CONSENT OF GBH CPAS, PC
<TEXT>
Document 3 - file: fs82017ex23i_actiniumpharma.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex5i_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: ex5i_01.jpg

</DOCUMENT>
</SEC-DOCUMENT>